Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-13-022383
Filing Date
2013-04-17
Accepted
2013-04-17 06:11:58
Documents
9
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K mainbody.htm 10-K 901358
2 EXHIBIT 10.32 ex10_32.htm EX-10.32 11590
3 EXHIBIT 10.33 ex10_33.htm EX-10.33 16591
4 EXHIBIT 10.34 ex10_34.htm EX-10.34 99327
5 EXHIBIT 10.35 ex10_35.htm EX-10.35 98234
6 EXHIBIT 31.1 ex31_1.htm EX-31.1 7662
7 EXHIBIT 31.2 ex31_2.htm EX-31.2 7691
8 EXHIBIT 32.1 ex32_1.htm EX-32.1 4403
9 EXHIBIT 32.2 ex32_2.htm EX-32.2 4063
  Complete submission text file 0001144204-13-022383.txt   1152201
Mailing Address 675 ALMANOR AVE. SUNNYVALE CA 94085
Business Address 675 ALMANOR AVE. SUNNYVALE CA 94085 (408) 737-2734
Amarantus Bioscience Holdings, Inc. (Filer) CIK: 0001424812 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 333-148922 | Film No.: 13765714
SIC: 2834 Pharmaceutical Preparations